Evaluation Baseline Report: Brucellosis Vaccine Challenge Project

Evaluators found that the vaccine market is weak and no new vaccines to control Brucellosis have been developed in recent years

From:
Foreign, Commonwealth & Development Office
Published
14 August 2020
Document Type:
Evaluation Report
Theme:
Agriculture
Authors:
Abt Associates

Abstract

This baseline report by External Evaluator Abt Associates describes the Brucellosis vaccine landscape at baseline. Evaluators found that the vaccine market is weak and no new vaccines to control Brucellosis have been developed in recent years. Evaluators also found that the Milestone 1 prize seemed to incentivize some new entities to initiate Brucellosis vaccine R&D.

This work is part of the AgResults programme

Citation

Abt Associates, August 2020. Evaluation Baseline Report: Brucellosis Vaccine Challenge Project. Rockville, MD: Abt Associates.

Evaluation Baseline Report: Brucellosis Vaccine Challenge Project

Updates to this page

Published 14 August 2020
Contents